Thyroid disease

Epidemiology and Management of Moderate to Severe Thyroid Eye Disease in the United States: Analysis of a Healthcare Claims Database

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

The estimated incidence and prevalence rates of TED demonstrate the considerable impact of this disease in the United States, making the creation of a specific ICD code imperative for effective healthcare planning and management.

Study context

Population
Patients with moderate to severe thyroid eye disease (TED) in the United States, Inovalon deidentified claims database (claims through 2019)
Exposure
Sensitive definition vs Specific definition
Outcome
Incidence and prevalence of moderate to severe TED
Methodological detailshealthcare claims database, sensitive and specific case definitions
  • Healthcare claims database
  • Sensitive and specific case definitions

Main finding

As reported in the abstract

Adjusted incidence rate (age- and gender-adjusted), per 100,000 person-years
GroupValueWomenMen
Sensitive definition8.97 per 100,000 person-years13.494.27
Specific definition4.37 per 100,000 person-years6.592.05

Value

Sensitive definition8.97 per 100,000 person-years
Specific definition4.37 per 100,000 person-years

Women

Sensitive definition13.49
Specific definition6.59

Men

Sensitive definition4.27
Specific definition2.05

Observational data: associations, not effects.

Further findings

Adjusted prevalence rate, per 100,000 persons

Women Sensitive definition 66.00 · Specific definition 31.18

Men Sensitive definition 21.39 · Specific definition 9.50

Patient characteristics and management

Prevalent patients with hypertension
> 40%
Preponderance of women
Steroids were the most frequently prescribed medication
Impact of teprotumumab not captured (claims only through 2019)

Original publication

Epidemiology and Management of Moderate to Severe Thyroid Eye Disease in the United States: Analysis of a Healthcare Claims Database. Clin Endocrinol (Oxf). Published 17 December 2024. doi:10.1111/cen.15183

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.